Bax deficiency partially corrects interleukin-7 receptor α deficiency

Immunity

Volumn 17, Issue 5, 2002, Pages 561-573

  Khaled, Annette R ^a   Li, Wen Qing ^a   Huang, Jiaqiang ^a   Fry, Terry J ^b   Khaled, Amr S ^c   Mackall, Crystal L ^b   Muegge, Kathrin ^d   Young, Howard A ^a   Durum, Scott K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; PROTEIN; PROTEIN BAD; PROTEIN BAX; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL DEATH; CELL MATURATION; CONTROLLED STUDY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DEPLETION; PROTEIN FUNCTION; REVERTANT; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMOCYTE;

EID: 0036849781     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(02)00450-8     Document Type: Article

References (48)

1. Akashi K., Kondo M., von Freeden-Jeffry U., Murray R., Weissman I.L. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell. 89:1997;1033-1041.
2. Bouillet P., Purton J.F., Godfrey D.I., Zhang L.C., Coultas L., Puthalakath H., Pellegrini M., Cory S., Adams J.M., Strasser A. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature. 415:2002;922-926.
3. Brugnera E., Bhandoola A., Cibotti R., Yu Q., Guinter T.I., Yamashita Y., Sharrow S.O., Singer A. Coreceptor reversal in the thymus. signaled CD4+8+ thymocytes initially terminate CD8 transcription even when differentiating into CD8+ T cells Immunity. 13:2000;59-71.
4. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 96:1999;857-868.
5. Candeias S., Muegge K., Durum S.K. IL-7 receptor and VDJ recombination. trophic versus mechanistic actions Immunity. 6:1997;501-508. a.
6. Candeias S., Peschon J.J., Muegge K., Durum S.K. Defective T-cell receptor gamma gene rearrangement in interleu-kin-7 receptor knockout mice. Immunol. Lett. 57:1997;9-14. b.
7. Cao X., Shores E.W., Hu-Li J., Anver M.R., Kelsall B.L., Russell S.M., Drago J., Noguchi M., Grinberg A., Bloom E.T. Defective lymphoid development in mice lacking expression of the common cytokine receptor chain. Immunity. 2:1995;223-238.
8. Datta S.R., Katsov A., Hu L., Petros A., Fesik S.W., Yaffe M.B., Greenberg M.E. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol. Cell. 6:2000;41-51.
9. Deckwerth T.L., Elliott J.L., Knudson C.M., Johnson E.M.J., Snider W.D., Korsmeyer S.J. BAX is required for neuronal death after trophic factor deprivation and during development. Neuron. 17:1996;401-411.
10. del-Peso L., Gonzalez G.M., Page C., Herrera R., Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science. 278:1997;687-689.
11. Dijkers P.F., Medema R.H., Lammers J.W., Koenderman L., Coffer P.J. Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr. Biol. 10:2000;1201-1204.
12. Dijkers P.F., Birkenkamp K.U., Lam E.W., Thomas N.S., Lammers J.W., Koenderman L., Coffer P.J. FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal. protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity J. Cell Biol. 156:2002;531-542.
13. Downward J. How BAD phosphorylation is good for survival. Nat. Cell Biol. 1:1999;E33-E35.
14. Durum S.K., Candeias S., Nakajima H., Leonard W.J., Baird A.M., Berg L.J., Muegge K. Interleukin 7 receptor control of T cell receptor gamma gene rearrangement. role of receptor-associated chains and locus accessibility J. Exp. Med. 188:1998;2233-2241.
15. Griffiths G.J., Corfe B.M., Savory P., Leech S., Esposti M.D., Hickman J.A., Dive C. Cellular damage signals promote sequential changes at the N-terminus and BH-1 domain of the pro-apoptotic protein Bak. Oncogene. 20:2001;7668-7676.
16. Hofmeister R., Khaled A.R., Benbernou N., Rajnavolgyi E., Muegge K., Durum S.K. Interleukin-7. physiological roles and mechanisms of action Cytokine Growth Factor Rev. 10:1999;41-60.
17. Hsu S.Y., Kaipia A., McGee E., Lomeli M., Hsueh A.J. Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members. Proc. Natl. Acad. Sci. USA. 94:1997;12401-12406.
18. Khaled A.R., Kim K., Hofmeister R., Muegge K., Durum S.K. Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH. Proc. Natl. Acad. Sci. USA. 96:1999;14476-14481.
19. Khaled A.R., Moor A.N., Li A., Kim K., Ferris D.K., Muegge K., Fisher R.J., Fliegel L., Durum S.K. Trophic factor withdrawal. p38 mitogen-activated protein kinase activates NHE1, which induces intracellular alkalinization Mol. Cell. Biol. 21:2001;7545-7557. a.
20. Khaled A.R., Reynolds D.A., Young H.A., Thompson C.B., Muegge K., Durum S.K. Interleukin-3 withdrawal induces an early increase in mitochondrial membrane potential unrelated to the Bcl-2 family. Roles of intracellular pH, ADP transport, and F(0)F(1)-ATPase. J. Biol. Chem. 276:2001;6453-6462. b.
21. Kim K., Lee C.K., Sayers T.J., Muegge K., Durum S.K. The trophic action of IL-7 on pro-T cells. inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways J. Immunol. 160:1998;5735-5741.
22. Knudson C.M., Korsmeyer S.J. Bcl-2 and Bax function independently to regulate cell death. Nat. Genet. 16:1997;358-363.
23. Knudson C.M., Tung K.S., Tourtellotte W.G., Brown G.A., Korsmeyer S.J. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science. 270:1995;96-99.
24. Kondo M., Akashi K., Domen J., Sugamura K., Weissman I.L. Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common γ chain-deficient mice. Immunity. 7:1997;155-162.
25. Lee C.K., Kim K., Welniak L.A., Murphy W.J., Muegge K., Durum S.K. Thymic emigrants isolated by a new method possess unique phenotypic and functional properties. Blood. 97:2001;1360-1369.
26. Lindsten T., Ross A.J., King A., Zong W.X., Rathmell J.C., Shiels H.A., Ulrich E., Waymire K.G., Mahar P., Frauwirth K.et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol. Cell. 6:2000;1389-1399.
27. Maki K., Sunaga S., Komagata Y., Kodaira Y., Mabuchi A., Karasuyama H., Yokomuro K., Miyazaki J.I., Ikuta K. Interleukin 7 receptor-deficient mice lack γδ T cells. Proc. Natl. Acad. Sci. USA. 93:1996;7172-7177.
28. Maraskovsky E., O'Reilly L.A., Teepe M., Corcoran L.M., Peschon J.J., Strasser A. Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/- mice. Cell. 89:1997;1011-1019.
29. Maraskovsky E., Peschon J.J., McKenna H., Teepe M., Strasser A. Overexpression of Bcl-2 does not rescue impaired B lymphopoiesis in IL-7 receptor-deficient mice but can enhance survival of mature B cells. Int. Immunol. 10:1998;1367-1375.
30. Matsuzaki Y., Nakayama K., Tomita T., Isoda M., Loh D.Y., Nakauchi H. Role of bcl-2 in the development of lymphoid cells from the hematopoietic stem cell. Blood. 89:1997;853-862.
31. Mok C.L., Gil-Gomez G., Williams O., Coles M., Taga S., Tolaini M., Norton T., Kioussis D., Brady H.J. Bad can act as a key regulator of T cell apoptosis and T cell development. J. Exp. Med. 189:1999;575-586.
32. Nakajima H., Leonard W.J. Role of Bcl-2 in alpha beta T cell development in mice deficient in the common cytokine receptor gamma-chain. the requirement for Bcl-2 differs depending on the TCR/MHC affinity J. Immunol. 162:1999;782-790.
33. Namen A.E., Schmierer A.E., March C.J., Overell R.W., Park L.S., Urdal D.L., Mochizuki D.Y. B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors. J. Exp. Med. 167:1988;988-1002.
34. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
35. Patel T.D., Jackman A., Rice F.L., Kucera J., Snider W.D. Development of sensory neurons in the absence of NGF/TrkA signaling in vivo. Neuron. 25:2000;345-357.
36. Peschon J.J., Morrissey P.J., Grabstein K.H., Ramsdell F.J., Maraskovsky E., Gliniak B.C., Park L.S., Ziegler S.F., Williams D.E., Ware C.B.et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180:1994;1955-1960.
37. Sasaki T., Irie-Sasaki J., Jones R.G., Oliveira-dos-Santos A., Stanford W.L., Bolon B., Wakeham A., Itie A., Bouchard D., Kozieradzki I.et al. Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration. Science. 287:2000;1040-1046.
38. Strasser A., Harris A.W., Vaux D.L., Webb E., Bath M.L., Adams J.M., Cory S. Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. Curr. Top. Microbiol. Immunol. 166:1990;175-181.
39. Strasser A., Harris A.W., Cory S. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell. 67:1991;889-899.
40. Vacchio M.S., Ashwell J.D. Glucocorticoids and thymocyte development. Semin. Immunol. 12:2000;475-485.
41. Vander H.M., Plas D.R., Rathmell J.C., Fox C.J., Harris M.H., Thompson C.B. Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol. Cell. Biol. 21:2001;5899-5912.
42. Veis D.J., Sorenson C.M., Shutter J.R., Korsmeyer S.J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell. 75:1993;229-240.
43. Venkitaraman A.R., Cowling R.J. Interleukin-7 induces the association of phosphatidylinositol 3-kinase with the alpha chain of the interleukin-7 receptor. Eur. J. Immunol. 24:1994;2168-2174.
44. von-Freeden-Jeffry U., Vieira P., Lucian L.A., McNeil T., Burdach S.E., Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181:1995;1519-1526.
45. Wei M.C., Zong W.X., Cheng E.H., Lindsten T., Panoutsakopoulou V., Ross A.J., Roth K.A., MacGregor G.R., Thompson C.B., Korsmeyer S.J. Proapoptotic BAX and BAK. a requisite gateway to mitochondrial dysfunction and death Science. 292:2001;727-730.
46. Wen R., Wang D., McKay C., Bunting K.D., Marine J.C., Vanin E.F., Zambetti G.P., Korsmeyer S.J., Ihle J.N., Cleveland J.L. Jak3 selectively regulates Bax and Bcl-2 expression to promote T-cell development. Mol. Cell. Biol. 21:2001;678-689.
47. Yin X.M., Wang K., Gross A., Zhao Y., Zinkel S., Klocke B., Roth K.A., Korsmeyer S.J. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature. 400:1999;886-891.
48. Zong W.X., Lindsten T., Ross A.J., MacGregor G.R., Thompson C.B. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 15:2001;1481-1486.